ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast to File BLA for Ryoncil FDA Approval Next Week
|
|
trststl
|
181 |
80K |
16 |
03/07/24 |
03/07/24 |
ASX - By Stock
|
181
|
80K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
trststl
|
10K |
3.0M |
3 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
10K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Rem-L Needed NOW
|
|
trststl
|
179 |
49K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
179
|
49K
|
3
|
|
ASX - By Stock
|
MSB Biotech |
Re:
NSW COVID FORECAST
|
|
trststl
|
40 |
11K |
5 |
08/09/21 |
08/09/21 |
ASX - By Stock
|
40
|
11K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
trststl
|
1.0K |
424K |
3 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
1.0K
|
424K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
trststl
|
175 |
42K |
10 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
175
|
42K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
trststl
|
273 |
142K |
4 |
10/02/21 |
10/02/21 |
ASX - By Stock
|
273
|
142K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Webcast
|
|
trststl
|
183 |
95K |
5 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
183
|
95K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
COVID-19 USA Daily Numbers
|
|
trststl
|
675 |
196K |
0 |
10/12/20 |
10/12/20 |
ASX - By Stock
|
675
|
196K
|
0
|
|
General
|
|
Re:
General Information
|
|
trststl
|
3.1K |
685K |
2 |
08/12/20 |
08/12/20 |
General
|
3.1K
|
685K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
|
|
trststl
|
445 |
196K |
0 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
445
|
196K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Conflict of Interest Evidence Thread - C. Hinrichs in ODAC Meeting
|
|
trststl
|
97 |
41K |
12 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
97
|
41K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
New Wuhan WH advisor.
|
|
trststl
|
63 |
14K |
0 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
63
|
14K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
New Wuhan WH advisor.
|
|
trststl
|
63 |
14K |
2 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
63
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
New Wuhan WH advisor.
|
|
trststl
|
63 |
14K |
2 |
03/09/20 |
03/09/20 |
ASX - By Stock
|
63
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
ARDS trials insights from earnings webcast
|
|
trststl
|
21 |
10K |
21 |
29/08/20 |
29/08/20 |
ASX - By Stock
|
21
|
10K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Annual Financial Results Presentation
|
|
trststl
|
97 |
43K |
11 |
27/08/20 |
27/08/20 |
ASX - By Stock
|
97
|
43K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
trststl
|
425 |
193K |
8 |
26/08/20 |
26/08/20 |
ASX - By Stock
|
425
|
193K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trststl
|
13K |
5.0M |
1 |
19/08/20 |
19/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
trststl
|
2.3K |
919K |
5 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
2.3K
|
919K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trststl
|
13K |
5.0M |
1 |
18/08/20 |
18/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
trststl
|
18K |
7.0M |
1 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trststl
|
13K |
5.0M |
0 |
17/08/20 |
17/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
trststl
|
13K |
5.0M |
1 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
13K
|
5.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
trststl
|
854 |
434K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
434K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
trststl
|
854 |
434K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
854
|
434K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
trststl
|
11K |
3.5M |
3 |
06/08/20 |
06/08/20 |
ASX - By Stock
|
11K
|
3.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
trststl
|
18K |
7.0M |
10 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
trststl
|
18K |
7.0M |
4 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
18K
|
7.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Insurance Coverage for aGVHD in the US
|
|
trststl
|
80 |
34K |
3 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
80
|
34K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
trststl
|
425 |
193K |
1 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
425
|
193K
|
1
|
|